Enavogliflozin (DWP-16001), an antidiabetic agent, is an orally active, best-in-class and selective sodium-glucose cotransporter-2 (SGLT-2) inhibitor[1][2][3].
Molecular Weight:
446.92
Purity:
98.43
CAS Number:
[1415472-28-4]
Formula:
C24H27ClO6
Target:
SGLT
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted